AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Tamamura, H Sugioka, M Odagaki, Y Omagari, A Kan, Y Oishi, S Nakashima, H Yamamoto, N Peiper, SC Hamanaka, N Otaka, A Fujii, N
Citation: H. Tamamura et al., Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity, BIOORG MED, 11(3), 2001, pp. 359-362

Authors: Tamamura, H Sugioka, M Odagaki, Y Omagari, A Kan, Y Oishi, S Nakashima, H Yamamoto, N Peiper, SC Hamanaka, N Otaka, A Fujii, N
Citation: H. Tamamura et al., Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity (vol 11, pg 359, 2001), BIOORG MED, 11(17), 2001, pp. 2409-2409

Authors: Tanaka, R Yoshida, A Murakami, T Baba, E Lichtenfeld, J Omori, T Kimura, T Tsurutani, N Fujii, N Wang, ZX Peiper, SC Yamamoto, N Tanaka, Y
Citation: R. Tanaka et al., Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection, J VIROLOGY, 75(23), 2001, pp. 11534-11543

Authors: Navenot, JM Wang, ZX Trent, JO Murray, JL Hu, QX DeLeeuw, L Moore, PS Chang, Y Peiper, SC
Citation: Jm. Navenot et al., Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: Differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II binding, J MOL BIOL, 313(5), 2001, pp. 1181-1193

Authors: Tamamura, H Omagari, A Oishi, S Kanamoto, T Yamamoto, N Peiper, SC Nakashima, H Otaka, A Fujii, N
Citation: H. Tamamura et al., Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads todevelopment of effective anti-HIV agents with very high selectivity indexes, BIOORG MED, 10(23), 2000, pp. 2633-2637

Authors: Hu, QX Barry, AP Wang, ZX Connolly, SM Peiper, SC Greenberg, ML
Citation: Qx. Hu et al., Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis, J VIROLOGY, 74(24), 2000, pp. 11858-11872

Authors: Hu, QX Trent, JO Tomaras, GD Wang, ZX Murray, JL Conolly, SM Navenot, JM Barry, AP Greenberg, ML Peiper, SC
Citation: Qx. Hu et al., Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization, J MOL BIOL, 302(2), 2000, pp. 359-375

Authors: Dawson, TC Lentsch, AB Wang, ZX Cowhig, JE Rot, A Maeda, N Peiper, SC
Citation: Tc. Dawson et al., Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC), BLOOD, 96(5), 2000, pp. 1681-1684

Authors: Fernandez, EJ Wilken, J Thompson, DA Peiper, SC Lolis, E
Citation: Ej. Fernandez et al., Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation, BIOCHEM, 39(42), 2000, pp. 12837-12844

Authors: Tecimer, T Dlott, J Chuntharapai, A Martin, AW Peiper, SC
Citation: T. Tecimer et al., Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells, ARCH PATH L, 124(4), 2000, pp. 520-525

Authors: Liwang, AC Wang, ZX Sun, Y Peiper, SC Liwang, PJ
Citation: Ac. Liwang et al., The solution structure of the anti-HIV chemokine vMIP-II, PROTEIN SCI, 8(11), 1999, pp. 2270-2280

Authors: Liu, XH Hadley, TJ Xu, L Peiper, SC Ray, PE
Citation: Xh. Liu et al., Up-regulation of Duffy antigen receptor expression in children with renal disease, KIDNEY INT, 55(4), 1999, pp. 1491-1500

Authors: Murakami, T Zhang, TY Koyanagi, Y Tanaka, Y Kim, J Suzuki, Y Minoguchi, S Tamamura, H Waki, M Matsumoto, A Fujii, N Shida, H Hoxie, JA Peiper, SC Yamamoto, N
Citation: T. Murakami et al., Inhibitory mechanism of the CXCR4 antagonist t22 against human immunodeficiency virus type 1 infection, J VIROLOGY, 73(9), 1999, pp. 7489-7496

Authors: Doranz, BJ Orsini, MJ Turner, JD Hoffman, TL Berson, JF Hoxie, JA Peiper, SC Brass, LF Doms, RW
Citation: Bj. Doranz et al., Identification of CXCR4 domains that support coreceptor and chemokine receptor functions, J VIROLOGY, 73(4), 1999, pp. 2752-2761

Authors: Wang, ZX Lee, BH Murray, JL Bonneau, F Sun, Y Schweickert, V Zhang, TY Peiper, SC
Citation: Zx. Wang et al., CCR5 HIV-1 coreceptor activity - Role of cooperativity between residues inN-terminal extracellular and intracellular domains, J BIOL CHEM, 274(40), 1999, pp. 28413-28419

Authors: LiWang, AC Cao, JJ Zheng, H Lu, ZH Peiper, SC LiWang, PJ
Citation: Ac. Liwang et al., Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein, BIOCHEM, 38(1), 1999, pp. 442-453

Authors: Zhao, SF Li, W Dornadula, G Dicker, D Hoxie, J Peiper, SC Pomerantz, RJ Duan, LX
Citation: Sf. Zhao et al., Chemokine receptors and the molecular basis for human immunodeficiency virus type 1 entry into peripheral hematopoietic stem cells and their progeny, J INFEC DIS, 178(6), 1998, pp. 1623-1634
Risultati: 1-17 |